Navigation Links
Late-stage melanoma results in economic burden
Date:3/15/2010

In an article published in the March 2010 Archives of Dermatology, researchers report that in the United States, melanoma treatment in late stages of the disease is of significant cost in the population 65 years and older.

The incidence of melanoma has risen dramatically over the years, and older white men have the highest rate of mortality. Epidemiologists say that one in 49 men and one in 73 women are affected in a lifetime, in contrast to one in 1,500 persons in the 1930s. The American Cancer Society reports that melanoma is the sixth most commonly diagnosed cancer in the United States.

"We already know the more quickly melanoma can be detected and treated, the lower the mortality rate," says Suephy C. Chen, MD, MS, assistant professor in the Department of Dermatology at Emory University School of Medicine, and principal investigator of the study.

"The data from this study help show that early detection is also very important in decreasing the economic burden from melanoma, especially in the older population."

The researchers gathered data from the Surveillance, Epidemiology and End Results (SEER)Medicare-linked population-based database for fiscal years 1991-1996 of persons 65 years or older who had late-stage melanoma. Their findings showed that average monthly, per-patient melanoma charges were $2,194 during the initial four months of treatment; dropped to $902 during the interim phase; but increased to $3,933 during the terminal six months of treatment.

The study authors concluded from the data that if all patients were diagnosed and treated in stage 0 or 1, the annual direct costs for the population 65 years or older would be between $99 million and $16 million 40-65 percent of the current costs of $249 million.

"The US population is aging rapidly," explains Chen. Routine screening of these individuals to diagnose melanoma before it reaches an advanced stage will not only impact the physical outcome, but could also vastly reduce the financial burden of the disease."


'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Related medicine news :

1. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
2. Genes signal late-stage laryngeal cancer, poorer outcome
3. Surgery not necessary for most late-stage colorectal cancers
4. City-dwellers have higher risk of late-stage cancer than rural residents
5. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
6. Bone Cement Eases Pain of Late-Stage Cancers
7. CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
8. Broccoli compound targets key enzyme in late-stage cancer
9. Patients own infection-fighting T cells put late-stage melanoma into long-term remission
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. Drug Helps Fight Late-Stage Colon Cancer in Some Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... , ... The producers of Enterprises TV are pleased to present ... world of instantaneous consumption proves very convenient for businesses. With new technologies constantly becoming ... which pollutes our air, water, and soil. It can also threaten the lives of ...
(Date:2/13/2016)... , ... February 13, 2016 , ... In the early ... They’ll groom themselves to perfection, go out of their way to be romantic, and ... just take a look at any online dating profile. , A recent study ...
(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed ... p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed ... pharmaceutical products, garnering increased attention from all stakeholders in the development of new ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... that nominations have closed for the ISE Southeast Awards 2016. Finalists and winners ... at the ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... -- Stem cells are primitive cells found in all ... capacity to differentiate into mature cell types Stem cells ... mouse embryonic stem cells were derived from embryos in ... first culturing of embryonic stem cells from non-human primates ... 2006 As a result of these discoveries, stem cells ...
Breaking Medicine Technology: